Prestige Consumer Healthcare
PBH
#3929
Rank
NZ$5.19 B
Marketcap
NZ$105.61
Share price
2.37%
Change (1 day)
-27.25%
Change (1 year)

P/S ratio for Prestige Consumer Healthcare (PBH)

P/S ratio as of December 2025 (TTM): 2.72

According to Prestige Consumer Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.65. At the end of 2025 the company had a P/S ratio of 2.79.

P/S ratio history for Prestige Consumer Healthcare from 2005 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20252.79-19.48%
20243.4729.42%
20232.68-4.22%
20222.80-2.68%
20212.8757.36%
20201.83-14.52%
20192.1432.3%
20181.61-29.68%
20172.30-29.3%
20163.25-5.72%
20153.4426.98%
20142.71-10.89%
20133.0479.63%
20121.6920.28%
20111.41-26.67%
20101.9244.81%
20091.33-19.62%
20081.6543.07%
20071.15-43.19%
20062.03-4.25%
20052.12

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
GlaxoSmithKline
GSK
2.32-14.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
2.33-14.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
0.0016-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.40 98.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
2.64-2.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
4.47 64.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
3.85 41.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
0.2544-90.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
1.85-32.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.86 78.90%๐Ÿ‡บ๐Ÿ‡ธ USA